London, June 18, 2026, 14:07 BST
- Rentokil shares slipped 3.73% to 425.79 pence, putting them roughly 16% under the 52-week peak.
- The stock is down about 5.6% across two sessions, dropping 1.95% Wednesday. The FTSE 100 rose 0.14% that day.
- The company’s next financial update is its interim results on July 30.
Rentokil Initial shares dropped again Thursday, underperforming the FTSE 100. Investors are still looking for clearer signs that the pest-control company’s North American rebound will last into the busy summer months.
London stocks slid. The FTSE 100 dropped 0.87% after the Bank of England left interest rates at 3.75%. Investors also reacted to a more hawkish Fed and its signals on future hikes. Rentokil lagged the broader move by almost three percentage points. “The conditions don’t seem in place for sustained inflationary pressure,” said Luke Bartholomew, deputy chief economist at Aberdeen. Reuters
Rentokil shares fell without a new trading update. The company’s website kept the April 16 first-quarter numbers as its most recent results, and the May 21 North America leadership announcement as its latest news. With nothing new out, there’s no clear stock trigger; the drop looks tied to uncertainty around execution.
First-quarter revenue was up 4.3% at $1.677 billion. Organic revenue, which strips out currency and deals, increased 3.4%. North America delivered $995 million, accounting for almost 60% of the total. Organic growth in pest control hit 4.1%. Customer retention held steady at 80.4%. CEO Mike Duffy said there was “continued momentum in North America” and maintained the full-year forecast in line with what the market expects.
Comparisons with Rollins, Orkin’s parent and a major US competitor, still set a high bar. Rollins posted 6.6% organic revenue growth and 10.2% total growth for the first quarter. CEO Jerry Gahlhoff said, “Our peak season is off to a strong start.” Still, adjusted operating margin dropped by 100 basis points to 16.9%. The companies differ in their businesses and how they account for things, but Rollins is a practical read on US demand. Rollins, Inc.
That puts more pressure on Rentokil. Keeping retention steady and raising prices might help revenue, but investors want to see more volume growth in services, better sales results, and higher margins. Thursday’s reaction shows the market isn’t ready to reward the company for the initial signs of progress shared in April.
Rafael Carrasco will step in as North America chief executive on Aug. 3, right after the interim results. Carrasco used to run big route-focused teams at WM and worked on the $7.2 billion Stericycle deal. At Rentokil, he said he aims to focus on “driving operational excellence,” pointing to the weight the firm puts on daily execution for its investment story. Rentokil Initial
The selling may have gone too far if summer demand shows up, if customer numbers hold, or if field work picks up faster than forecasts. On the other hand, if North American service growth flatlines, costs stay high or the management change slows things down, then margins and cash flow risk missing targets.
The July report is set to matter more now. Investors are focused on North American organic growth, retention, operating margins, and debt reduction, but the key question is if first-quarter gains held up as pest season hit its peak.
